InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Kelly Timothy Edwin, Chief Financial Officer. Director active across 1 companies, notably Praxis Precision Medicines, Inc.. Cumulatively, 6 filings have been published. Total volume traded: €145k. The latest transaction was disclosed on 9 June 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations6 total
€16,62110,000 shares@ €1.66210.0002% mcap9.9% of flow
Common Stock
SEC:0001689548-22-000078:0·
Ideal exit: 6 Mar 2023 (T+270)
€21,9112,585 shares@ €8.47630.0003% mcap13.1% of flow
Common Stock
SEC:0001689548-22-000042:0·
024,000 shares0
Common Stock
SEC:0001104659-22-003155·
024,000 shares0
Common Stock
SEC:0001104659-22-003155:0·
€64,4093,905 shares@ €16.4941100.0% of flow
Common Stock
SEC:0001689548-21-000083·
Ideal exit: 28 May 2022 (T+270)
€64,4093,905 shares@ €16.49410.0009% mcap38.5% of flow
Common Stock
SEC:0001689548-21-000083:0·
Ideal exit: 28 May 2022 (T+270)
6 of 6 declarations
About Kelly Timothy Edwin
Timothy Edwin Kelly is the Chief Financial Officer at Praxis Precision Medicines, Inc. He is responsible for the company's financial management, including financial planning, risk management, and compliance. With a strong background in finance, he contributes to the overall financial strategy and informed decision-making to support Praxis' growth. His role is crucial in ensuring the financial health of the company.
